General Information of Binding Target of SBP (BTS) (ID: ST00295)
BTS Name
Fiber protein
Synonyms
SPIKE; Protein IV
BTS Type
Protein
Family
Adenoviridae fiber family
Organism
Human adenovirus C serotype 2 (HAdV-2) (Human adenovirus 2)
Function
Forms spikes that protrude from each vertex of the icosahedral capsid. Interacts with host coxsackievirus and adenovirus receptor CXADR located at the cell tight junctions to provide virion initial attachment to target cell. The fiber protein binds to CXADR with a higher affinity than CXADR binds to itself, thereby blocking the cell-cell adhesion function of CXADR dimers and leading to local disruption of the tight junction. Fiber protein present on neo-synthesized particles may thus disrupt the junctional integrity in order to facilitate further neighboring cells infection. Fiber proteins are shed during virus entry, when virus is still at the cell surface. Fiber shedding is dependent on viral CXADR drifting motion and subsequent binding to immobile integrins. Heparan sulfate might also play a role in virus binding.
UniProt ID
P03275
UniProt Entry
SPIKE_ADE02
PFam
PF00541 ; PF00608
Gene ID
2652999
Sequence
MKRARPSEDTFNPVYPYDTETGPPTVPFLTPPFVSPNGFQESPPGVLSLRVSEPLDTSHG
MLALKMGSGLTLDKAGNLTSQNVTTVTQPLKKTKSNISLDTSAPLTITSGALTVATTAPL
IVTSGALSVQSQAPLTVQDSKLSIATKGPITVSDGKLALQTSAPLSGSDSDTLTVTASPP
LTTATGSLGINMEDPIYVNNGKIGIKISGPLQVAQNSDTLTVVTGPGVTVEQNSLRTKVA
GAIGYDSSNNMEIKTGGGMRINNNLLILDVDYPFDAQTKLRLKLGQGPLYINASHNLDIN
YNRGLYLFNASNNTKKLEVSIKKSSGLNFDNTAIAINAGKGLEFDTNTSESPDINPIKTK
IGSGIDYNENGAMITKLGAGLSFDNSGAITIGNKNDDKLTLWTTPDPSPNCRIHSDNDCK
FTLVLTKCGSQVLATVAALAVSGDLSSMTGTVASVSIFLRFDQNGVLMENSSLKKHYWNF
RNGNSTNANPYTNAVGFMPNLLAYPKTQSQTAKNNIVSQVYLHGDKTKPMILTITLNGTS
ESTETSEVSTYSMSFTWSWESGKYTTETFATNSYTFSYIAQE
Sequence Length
582
Synthetic Binding Protein (SBP) Targeting This BTS
SBP Name Highest Status Mechanism Affinity Application Details Ref
scFv anti-Fibre protein knob domain clone S11 Research Binder Kd: 3 nM Adenovirus infection [ICD-11: 1D90]
SBP Info
[1]
References
1 The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene Ther. 1997 Oct;4(10):1004-12.